Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
GM7K2ju5M6LbyZNG
